Bart Jan Kullberg, M.D., FRCP, FIDSA

Professor of Medicine and Infectious Diseases
Radboud univerity medical center

Disclosure: Amplyx (Individual(s) Involved: Self): Advisor or Review Panel member

Presentation(s):

• 147 - Clinical Safety and Efficacy of Novel Antifungal, Fosmanogepix, in the Treatment of Candidemia: Results from a Phase 2 Proof of Concept Trial

  Oral Abstract